CK2 in cancer: cellular and biochemical mechanisms and potential therapeutic target
MMJ Chua, CE Ortega, A Sheikh, M Lee… - Pharmaceuticals, 2017 - mdpi.com
CK2 genes are overexpressed in many human cancers, and most often overexpression is
associated with worse prognosis. Site-specific expression in mice leads to cancer …
associated with worse prognosis. Site-specific expression in mice leads to cancer …
Targeting CK2 in cancer: a valuable strategy or a waste of time?
CK2 is a protein kinase involved in several human diseases (ranging from neurological and
cardiovascular diseases to autoimmune disorders, diabetes, and infections, including …
cardiovascular diseases to autoimmune disorders, diabetes, and infections, including …
Protein kinase CK2–diverse roles in cancer cell biology and therapeutic promise
JH Trembley, BT Kren, M Afzal, GA Scaria… - Molecular and cellular …, 2023 - Springer
The association of protein kinase CK2 (formerly casein kinase II or 2) with cell growth and
proliferation in cells was apparent at early stages of its investigation. A cancer-specific role …
proliferation in cells was apparent at early stages of its investigation. A cancer-specific role …
Cats, cancer and comparative oncology
CM Cannon - Veterinary sciences, 2015 - mdpi.com
Naturally occurring tumors in dogs are well-established models for several human cancers.
Domestic cats share many of the benefits of dogs as a model (spontaneous cancers …
Domestic cats share many of the benefits of dogs as a model (spontaneous cancers …
CSNK2 in cancer: pathophysiology and translational applications
SW Strum, L Gyenis, DW Litchfield - British journal of cancer, 2022 - nature.com
Abstract Protein kinase CSNK2 (CK2) is a pleiotropic serine/threonine kinase frequently
dysregulated in solid and hematologic malignancies. To consolidate a wide range of …
dysregulated in solid and hematologic malignancies. To consolidate a wide range of …
Casein kinases as potential therapeutic targets
Introduction: The conventional term 'casein kinase'(CK) denotes three classes of kinases–
CK1, CK2 and Golgi-CK (G-CK)/Fam20C (family with sequence similarity 20, member C) …
CK1, CK2 and Golgi-CK (G-CK)/Fam20C (family with sequence similarity 20, member C) …
[HTML][HTML] Protein kinase CK2, a potential therapeutic target in carcinoma management
H Lian, M Su, Y Zhu, Y Zhou… - Asian Pacific journal of …, 2019 - ncbi.nlm.nih.gov
The Protein kinase CK2 (formerly known as casein kinase 2) is a highly conserved
serine/threonine kinase overexpressed in various human carcinomas and its high …
serine/threonine kinase overexpressed in various human carcinomas and its high …
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy
BT Kren, GM Unger, MJ Abedin, RI Vogel… - Breast cancer …, 2015 - Springer
Introduction Targeted therapies for aggressive breast cancers like triple negative breast
cancer (TNBC) are needed. The use of small interfering RNAs (siRNAs) to disable …
cancer (TNBC) are needed. The use of small interfering RNAs (siRNAs) to disable …
Targeted drug delivery systems and their therapeutic applications in cancer and immune pathological conditions
Background: More than a century ago, Paul Ehrlich proposed the idea of a drug working as
a “magic bullet” that selectively eliminates diseased cells without harming the surrounding …
a “magic bullet” that selectively eliminates diseased cells without harming the surrounding …
[HTML][HTML] Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma …
Glioblastoma multiforme (GBM) remains the deadliest brain tumor in adults. GBM tumors are
also notorious for drug and radiation resistance. To inhibit GBMs more effectively, polymalic …
also notorious for drug and radiation resistance. To inhibit GBMs more effectively, polymalic …